New SARS-CoV-2 test is a simple, cost-effective, and efficient alternative for SARS-CoV-2 testing

A new multiplex real-time RT-PCR assay performs as well as the modified Centers for Disease Control and Prevention (CDC) assay, yet can test three times more patients per run, scientists report.